4
Changes in Ownership
REGENERON PHARMACEUTICALS, INC. Filed Acc 0002009236-26-000003
SVP Controller sold 4,062 shares at an average $942.19 ($3,827,159)
- SVP Controller acquired 3,883 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Pitofsky Jason · SVP Controller
Table I: Non-derivative
11 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-11-04 | Exercise or conversion : show line 1 in the form | +1,500 | $726.53 | $1,089,795 | 5,772 | D |
| 2026-11-04 | Exercise or conversion : show line 2 in the form | +1,478 | $644.54 | $952,630 | 7,250 | D |
| 2026-11-04 | Exercise or conversion : show line 3 in the form | +905 | $492.00 | $445,260 | 8,155 | D |
| 2026-11-04 | Sale : show line 4 in the form | −439 | $939.57 | $412,471 | 7,716 | D |
| 2026-11-04 | Sale : show line 5 in the form | −575 | $940.46 | $540,765 | 7,141 | D |
| 2026-11-04 | Sale : show line 6 in the form | −982 | $941.58 | $924,632 | 6,159 | D |
| 2026-11-04 | Sale : show line 7 in the form | −1,215 | $942.31 | $1,144,907 | 4,944 | D |
| 2026-11-04 | Sale : show line 8 in the form | −529 | $943.53 | $499,127 | 4,415 | D |
| Open-market sales · 4,062 sh · avg $942.19 · $3,827,159 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-11-04 | Exercise or conversion : show line 12 in the form Non-Qualified Stock Option (right to buy) | −905 | 0 | D |
| 2026-11-04 | Exercise or conversion : show line 13 in the form Non-Qualified Stock Option (right to buy) | −1,478 | 500 | D |
| 2026-11-04 | Exercise or conversion : show line 14 in the form Non-Qualified Stock Option (right to buy) | −1,500 | 2,478 | D |
Loading xslF345X06/edgardoc.xml…